Aktuellt
SENASTE
Q-linea has expanded the ASTar panel, including 222 combinations based on 29 different antibiotics. The timing is good in our view as ASTar is in the early stage of the European launch. The ability to provide a fast AST answer in most cases, including the more unusual situations, is essential, and during 2022 the early clinical experience will be crucial. ASTar's expanded panel is a feature for future panels delivered, including early 2022. Our value proposition is a base of SEK 180 (Bull SEK 230 and Bear SEK 90).
LÄS MER
